Copenhagen-based virtual well being corporate focusing on persistent illness control First light Well being secured $13 million (€11.5 million) from current buyers Chr. Augustinus Fabrikker, the export and funding fund of Denmark (EIFO) and Trifork.
WHAT IT DOES
First light Well being’s platform and merchandise are utilized in oncology and for more than one sclerosis and uncommon pediatric prerequisites, like expansion problems, to lend a hand pharma corporations, sufferers and healthcare pros spice up results and affected person care by way of leveraging complex features in AI, information, proof era, medical integrations, personalization and attached well being.
Merck and Novartis are some of the corporations that experience followed First light’s choices.
The corporate will use the budget to marketplace its platform and product suite to international pharmaceutical corporations thru a software-as-a-service (SaaS) style.
“Our ambition is to be the worldwide chief in virtual well being, powering pharma’s next-generation merchandise and in the end making improvements to the lives of sufferers international,” Alexander Mandix Hansen, CEO of First light Well being, mentioned in a remark.
“This investment lets in us to carry our confirmed platform to extra markets and deepen our have an effect on.”
MARKET SNAPSHOT
In 2023, First light Well being partnered with Novartis to increase a prolonged situation control platform.
Beneath the collaboration, First light and Novartis constructed faraway tracking and control gear for persistent prerequisites the place they see an unmet want and considerations round illness development, like more than one sclerosis, high blood pressure, heart problems and breast most cancers.
The platform comprises affected person cellular apps, symptom tracking, virtual biomarkers, medical determination beef up products and services and digital hospital choices aimed toward particular illnesses and stipulations.
Different corporations within the persistent situation area come with Wellth, which secured $20 million in Sequence B investment in 2023.
The spherical used to be led by way of SignalFire, with participation from former Evolent Well being CEO Frank Williams and former buyers the Social Marketers’ Fund, CD Mission, Yabeo and the Partnership Fund for NYC.
In 2022, Omada Well being integrated behavioral well being beef up in its current methods for diabetes prevention and control, high blood pressure and musculoskeletal care.
The behavioral well being integration comprises nervousness and despair evaluation, sources to control social determinants of well being, pressure control and sleep gear. It gives care groups supplemented by way of psychological well being consultants and coaching, triage and steering in severe psychological well being crises.
That very same yr, the corporate raised a hefty $192 million in Sequence E investment, which it used to spend money on new hires, its tech street map for care personalization and its Omada Insights Lab.
Constancy Control & Analysis Corporate led the spherical, which integrated participation from aMoon, Perceptive Advisors, Wellington Control, Civilization Ventures and others.
